Unknown

Dataset Information

0

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment.

ABSTRACT:

SUBMITTER: Fioretto P 

PROVIDER: S-EPMC4969341 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment.

Fioretto Paola P   Stefansson Bergur V BV   Johnsson Eva E   Cain Valerie A VA   Sjöström C David CD  

Diabetologia 20160615 9

Similar Datasets

Unknown Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers.
| S-EPMC4850750 | biostudies-literature
Unknown Dapagliflozin in patients with type 2 diabetes mellitus.
| S-EPMC4321869 | biostudies-literature
Unknown Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial.
| S-EPMC11934004 | biostudies-literature
Unknown Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus.
| S-EPMC8245397 | biostudies-literature
Unknown Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus.
| S-EPMC5716679 | biostudies-literature
Unknown Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial.
| S-EPMC8343250 | biostudies-literature
Unknown Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.
| S-EPMC3973038 | biostudies-literature
Unknown Renal effects of dapagliflozin in patients with type 2 diabetes.
| S-EPMC4132377 | biostudies-literature
Unknown Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus.
| S-EPMC9545191 | biostudies-literature
Unknown Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment.
| S-EPMC5014795 | biostudies-literature